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The Na+/H+ exchanger (NHE) was first studied in renal systems and was thought 
to play a role in renal acidification as well as transepithelial water and salt transport. It has 
been shown since, however, that the Na+/H+ exchanger (or antiporter) is found not only 
in epithelial cells (Grinstein and Rothstein, 1986), but also is found in almost all cells, 
displaying a role in key cellular functions such as control of cell volume, regulation of 
intracellular pH, and initiation of cell growth and proliferation (Grinstein et al., 1992; 
Sardet et al., 1990). 
In pH regulation, the antiporter is responsible for allowing one Na+ ion into the 
cell for every H+ ion that is released from the cell. It has been demonstrated that a 
correlation exists between an increase in intracellular pH (pHj) and an increase in the rate 
of protein synthesis in sea urchin eggs (Grainger et al., 1979). It has further been 
demonstrated that an increase in pHi plays an important role in the regulation of synthesis 
of proteins that are key factors in Xenopus laevis oocyte meiotic maturation (Houle and 
Wasserman, 1983). As the pHi increases, the rate of protein synthesis also increases, and 
the rate of Xenopus oocyte maturation is dependent on the pHi (Wasserman et al., 1986). 
Due to the importance of pHi during oocyte meiotic maturation, the purpose of my study 
was to investigate the regulation of the Na+/H+ antiporter in Xenopus laevis oocytes. 
My working hypothesis was that the rise in pHi that occurs during oocyte 
maturation is the result of the phosphorylation of the Na+/H+ antiporter caused by one or 
more protein kinases. During oocyte meiotic maturation, there exists a protein kinase 
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cascade, activated by progesterone, which ultimately leads to germinal vesicle breakdown 
(GVBD) (Sagata et al., 1989). The following five protein kinases within this cascade were 
investigated in this study: c-mos kinase, raf-1 kinase, MAP kinase kinase, MAP kinase, 
and S6 kinase. The goal of my study was to determine which one of these protein kinases, 
if any, plays a role in the activation of the Na+/H+ antiporter during oocyte maturation. It 
has been noted that elevated levels of cAMP block the progesterone-induced increase in 
pHi during oocyte meiotic maturation (Rezai, 1994). It is unknown where within the 
protein kinase cascade cAMP blocks the increase in pHi. In order to answer these 
questions I utilized the following strategies: 
1) I attempted to activate the Na+JH+ antiporter by microinjecting one of the 
five active protein kinases into Xenopus laevis oocytes. 
2) I attempted to determine if this kinase is the only protein that is needed to 
activate the antiporter. 
3) I attempted to determine where in the kinase cascade cAMP blocks the pHi 
increase by artificially altering cAMP levels within the oocyte prior to the 
microinjection of each kinase. 
4) Propose which of the five kinases, if any, is responsible for the activation 
of the Na+JH+ antiporter during Xenopus oocyte maturation. 
Literature Review 
Oocyte meiotic maturation is the process responsible for preparing the egg for 
fertilization (Eckberg, 1988). Oocyte maturation has been studied in a variety of 
organisms, both vertebrate and invertebrate, but the most thorough research in this area 
has been achieved utilizing the amphibian as a model system (Smith, 1989). 
In Xenopus laevis, oogenesis is an asynchronous process having oocytes in 
different stages of growth all present in the ovary at the same time. The growth period of 
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oocytes has been divided into six stages, I-VI (Dumont, 1972), with stage VI being fully-
grown oocytes (1200-1300 µm in diameter). At this final stage, oocytes are arrested in late 
G2 phase of meiosis I until they are triggered by hormones to progress to the second 
meiotic metaphase, where they are capable of participating in fertilization (Smith, 1989). 
Only the stage VI oocytes are capable of responding to hormonal stimulation and resuming 
meiosis from prophase arrest (Wasserman et al., 1986). 
In vivo, meiotic maturation is initiated by luteinizing hormone (LH), a 
gonadotropin released from the anterior pituitary into the circulatory system. Upon 
reaching the ovary, LH stimulates the follicle cells surrounding the stage VI oocytes, 
causing the follicles to synthesize and release progesterone, a steroid hormone. 
Progesterone then acts on the oocytes to induce meiotic resumption (Masui and Markert, 
1971). The interaction between progesterone and the oocyte does not follow the typical 
steroid-target cell model. In other cell systems, steroids are usually translocated to the 
nucleus where they alter specific gene transcription (Beato, 1989). In oocytes, 
progesterone acts at the plasma membrane of the oocyte. The signal is then transduced 
across the plasma membrane into the cytoplasm of the cell where it is responsible for 
triggering a complex series of reactions ultimately leading to meiotic maturation of the 
oocyte. Experiments have been performed to confirm that progesterone has to act at the 
plasma membrane of the oocyte to induce meiotic maturation, and that progesterone does 
not induce maturation from within the cytoplasm of the oocyte. Microinjection of 
progesterone into the cytoplasm of stage VI oocytes of Rana pipiens and Xenopus laevis 
does not induce meiotic maturation (Masui and Markert, 1971; Wasserman et al., 1986). 
Progesterone that is covalently bound to polystyrene beads, so that it cannot pass through 
the plasma membrane, is able to induce meiotic maturation when applied to the oocyte 
surface (Godeau et al., 1978). Investigators have also identified a steroid receptor on the 
plasma membrane of Xenopus laevis oocytes via photoaffinity labeling (Sadler and 
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Maller, 1982; Blondeau and Baulieu, 1984). More recently, the steroid receptors on the 
plasma membrane were characterized utilizing radiolabeled progesterone to determine their 
binding affinity (Liu and Patino, 1993). 
During meiotic maturation, the oocyte nucleus (germinal vesicle, GV) migrates to 
the animal pole of the cell, the nuclear envelope undergoes dissolution (germinal vesicle 
breakdown, GVBD), the chromosomes condense, the spindle forms, and homologous 
chromosomes are segregated. During the migration of the germinal vesicle toward the 
animal pole, the pigment granules that are located at the pole are displaced. This 
displacement results in the formation of a white spot surrounded by a dark band made up 
of the displaced pigment granules, the first visible indication of oocyte maturation. 
Concurrent with these morphological events are several physiological events that 
take place within the oocyte during meiotic maturation. These events include an increase in 
intracellular Ca2+, a decrease in cAMP levels, an increase in intracellular pH, an increase 
in protein synthesis, an increase in total protein phosphorylation, and activation of 
maturation promoting factor (MPF), a cytoplasmic factor responsible for GVBD and 
chromosome condensation (Wasserman and Smith, 1978). 
The mechanism by which progesterone activates these morphological and 
physiological events that constitute oocyte maturation has been compared to the 
transmembrane signalling events of peptide hormones. It is thought that by changing the 
intracellular concentrations of second messengers, progesterone indirectly regulates the 
intracellular events. Two second messengers, inositol triphosphate (IP3) and 1,2-
diacylglycerol (DAG), are generated when membrane-bound phosphotidylinositol 4,5-
bisphosphate (PIP2) undergoes hydrolysis as a result of the activation of phospholipase 
C. IP3 triggers the release of Ca2+ from the endoplasmic reticulum, resulting in elevated 
levels of Ca2+ which activate calmodulin-dependent kinase (CAM), while DAG is 
responsible for activating protein kinase C (PKC) (reviewed by Eckberg, 1988; Smith, 
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1989). Cyclic AMP, another second messenger and known regulator of protein kinase A 
(PKA), decreases during oocyte maturation. This decrease in cAMP is due to 
progesterone inhibition of the cell's adenylate cyclase activity by inhibiting guanine 
nucleotide exchange on the associated Gs protein (Sadler and Maller, 1981; Sadler and 
Maller, 1983). 
One of the physiological events occurring during oocyte maturation is an increase 
in intracellular pH (pHi). Studies indicate that the 0.3-0.4 unit increase in pHi may directly 
or indirectly be responsible for the increase in the rate of protein synthesis during oocyte 
maturation. Stage VI Xenopus laevis oocytes have a pHi of 7 .2-7 .3 and a rate of protein 
synthesis of about 20 ng/hr, while mature oocytes have a pHi of 7.6-7.7 and a rate of 
protein synthesis of about 40 ng/hr. If a stage VI oocyte is subjected to artificial 
alk:alinization, an increase in the rate of protein synthesis occurs (Houle and Wasserman, 
1983). These data suggest that pHi is in some way responsible for the regulation of 
protein synthesis during maturation of the oocyte. 
The regulation of pHi has been investigated in several cell systems where pHi acts 
as a regulator for various cellular functions. The one similarity that appears to hold 
throughout most of the cell systems is that the increase in pHi seems to be the result of the 
stimulation of Na+/H+ antiporters. In Xenopus oocytes, if the extracellular sodium is 
replaced with choline chloride, or if amiloride (a Na+/H+ antiporter inhibitor) is used, the 
increase in pHi in response to progesterone is completely inhibited (Wasserman and 
Houle, 1984; Stith and Maller, 1985; Towle et al., 1991; Rezai, 1994). 
In mammalian cell systems, the Na+/H+ antiporter is proposed to be regulated via 
a phosphorylation event. It has been suggested that phosphorylation induces a 
conformational change within the Na+/H+ antiporter, causing it to acquire an increased 
affinity for cytoplasmic H+ (Wakabayashi et al., 1992; Borgese et al., 1992). In support 
of this proposal, investigators have demonstrated that concurrent with the increase in 
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antiporter activity, there is an increase in the phosphorylation of NHEl (Na+/H+ 
Exchanger 1), a transmembrane glycoprotein of 110 kDa in fibroblasts, epithelial cells, 
and blood platelets (Livne et al., 1991; Sardet et al., 1990; Wakabayashi et al., 1992; 
Grinstein et al., 1992; Guizouarn et al., 1993). With the general consensus being that the 
Na+/H+ antiporter is activated via phosphorylation, investigations have been performed 
using mammalian cell systems to determine which protein kinase(s) is involved in this 
event (Guizouarn et al., 1993; Wakabayashi et al., 1992). 
In Xenopus oocytes, protein kinases regulated by secondary messengers 
following progesterone stimulation were studied and it was found that neither Protein 
Kinase C, Protein Kinase A, nor Calcium-Calmodulin Kinase play a role in the activation 
of the Na+JH+ antiporter (Rezai, 1994). In addition, maturation promoting factor (MPF) 
H-1 kinase, a cytoplasmic kinase which is responsible for GVBD and chromosome 
condensation, does not appear to play a role in regulating oocyte pHi (Rezai, 1994). 
Another series of kinases within a cascade are known to be activated in response to 
progesterone stimulation during oocyte meiotic maturation. This progesterone-induced 
kinase cascade is: c-mos kinase ----> raf-1 kinase ----> MAP kinase kinase ----> MAP 
kinase----> S6 kinase. I have concentrated on the protein kinases within this cascade to 
determine which one, if any, is responsible for activation of the Na+/H+ antiporter in 
Xenopus laevis oocytes. 
The proto-oncogene protein product p39 c-mos kinase has been proposed to be the 
"initiator" of oocyte maturation (Sagata et al., 1989). Within one to two hours following 
progesterone stimulation, c-mos kinase is newly synthesized from stored mRNA and 
phosphorylated within the oocyte. c-mos kinase mRNA is found in only three types of 
tissues in adult Xenopus laevis; brain, testis, and ovary, with the ovary containing the 
highest concentrations (Sagata et al., 1988). Within the ovary, c-mos kinase mRNA 
expression is restricted to the oocytes, that is the germ line, not the somatic cells. On a per 
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oocyte level, the amount of c-mos kinase mRNA remains constant throughout oocyte 
growth and maturation, with the protein product appearing only in stage VI oocytes that 
have been stimulated by progesterone (Sagata et al., 1988). Injection of either c-mos 
kinase mRNA or c-mos kinase protein into stage VI oocytes, in the absence of 
progesterone stimulation, was sufficient to induce GVBD. In addition, injection of c-mos 
kinase antisense oligonucleotides into stage VI oocytes inhibited progesterone-induced 
GVBD (Sagata et al., 1988; Daar et al., 1993). Injection of c-mos kinase protein into 
stage VI oocytes that had been pre-treated with cycloheximide (an inhibitor of protein 
synthesis) was still capable of initiating GVBD in the absence of progesterone stimulation, 
whereas oocytes pre-treated with cycloheximide followed by progesterone treatment did 
not undergo GVBD (Yew et al., 1992). These results suggest that c-mos kinase is the 
only newly synthesized protein needed to initiate GVBD. 
Preliminary experiments have been performed that examined the role of c-mos 
kinase in the activation of the Na+JH+ antiporter (Rezai, 1994). A high dose of Maltose 
Binding Protein (MBP)-c-mos kinase protein fusion protein was capable of increasing the 
intracellular pH of stage VI oocytes that were not treated with progesterone. Since c-mos 
kinase rapidly activates other protein kinases within the kinase cascade, however, this 
study was unable to conclude if c-mos kinase directly regulates the Na+JH+ antiporter 
(Rezai, 1994). 
Further observations have been made concerning other protein kinases becoming 
phosphorylated and activated following c-mos kinase activation. It has been shown that 
MAP kinase (Mitogen Activated Protein kinase formerly known as Microtubule 
Associated Protein kinase) becomes activated both in cell-free extracts as well as in fully-
grown Xenopus oocytes subsequent to c-mos kinase stimulation, and that active c-mos 
kinase is capable of phosphorylating and activating purified MAP kinase kinase in vitro 
(Nebreda et al., 1993; Posada et al., 1993). Thus, c-mos kinase is an upstream activator 
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of the MAP kinase pathway within the cascade, and may possibly function directly 
through the activation of MAP kinase kinase. 
The protein kinase that immediately follows c-mos kinase within the cascade has 
not been determined at this point, but researchers have found that raf-1 kinase is required 
for progesterone-induced oocyte meiotic maturation and that it functions downstream of c-
mos kinase (Muslin et al., 1993). The gene encoding raf-1 kinase was first isolated from 
murine sarcoma retrovirus 3611 (Rapp, 1992). The protein product of the transforming 
gene of this retrovirus, v-raf protein, was compared to known amino acids sequences of 
tyrosine kinases as well as a phosphoamino acid analysis of the protein product itself, 
both results showing that the v-raf protein product is a serine/threonine kinase. Three 
genes have since been identified that code for the cellular homologs of v-raf in vertebrates, 
c-raf, A-raf, and B-raf. All three are classified as proto-oncogenes in that certain amino 
acid sequence mutations can cause oncogenic characteristics. All of the raf-1 proteins 
share three highly conserved regions (CRl, CR2, CR3) which make up the primary 
structure of these proteins. CR 1, which consists of amino acid residues 62-196, contains 
a binding domain for the ras molecule which is followed by a cysteine zinc finger motif. 
CR2, consisting of amino acid residues 255-268, is rich in serine and threonine residues 
which act as a major phosphorylation site for regulating kinase activity. CR3 consists of 
amino acid residues 331-625, is the conserved kinase domain of the protein. The protein 
itself can be subdivided into two regions, the regulatory region which consists of CRl and 
CR2 at the amino-terminus, and the catalytic region consisting of CR3 at the carboxy-
terminus. In order for raf-1 kinase to become activated, it has to be phosphorylated on 
serine residues, namely Ser43, Ser259, and Ser621 (Morrison et al., 1993). It has been 
hypothesized that the regulatory region acts as an autoinhibitor, with the mechanism not 
yet fully understood. It has been suggested that the regulatory region folds over the 
catalytic region, thereby inhibiting any enzymatic activity. Consistent with this hypothesis 
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were the observations from several investigators that excess expression of the regulatory 
region of raf-1 kinase blocked the activation of the kinase domain in a dominant negative 
manner, and that if the regulatory region in the whole enzyme was mutated or deleted 
altogether, a constitutively active raf-1 kinase was produced (Morrison et al., 1993; 
Fabian et al., 1993). 
In other cell systems, raf-1 kinases are located in the cytoplasm and play an 
important role in transmission of signals from cell surface receptors to transcription factors 
within the nucleus (Williams and Roberts, 1994). It has been shown that raf-1 kinase 
plays a role in the signal cascade shared by epidermal growth factor (EGF) and platelet-
derived growth factor (PDGF) (Kizaka-Kondoh et al., 1992). The data indicated 
biochemical links among activated EGF and PDGF receptors, the p21ras-GTPase-
activating protein mitogenic signalling system, and raf-1 kinase. Ras, like all known 
GTP-binding proteins, cycles between an active and inactive form, stimulated by several 
extracellular signals. Activated ras appears to act as a regulator of a protein kinase cascade 
(Hall, 1994). The following model has been proposed for the role of ras in raf-1 kinase 
activation. Activated ras recruits inactive raf-1 kinase to the plasma membrane by binding 
to the amino-terminal domain, but ras is not responsible for anchoring raf-1 kinase to the 
membrane. Raf-1 kinase appears to be attached to the membrane mainly via membrane 
cytoskeletal elements. A ras-independent event occurs by an unknown factor at the 
membrane level which unmasks the catalytic domain, which was previously covered by 
the amino-terminal regulatory domain, allowing phosphorylation at serine residues 259 
and 621, thereby activating raf-1 kinase (Stokoe et al., 1994; Daum et al., 1994; Williams 
et al., 1994). 
Raf-1 kinase may share common regulatory cofactors with PKC because of the 
similarity between amino acid motifs in the regulatory domains of the two kinases. This 
appears to be unlikely however, since diacylglycerol and phosphatidylserine, two lipid 
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modulators that function as regulatory cofactors for PKC, did not activate purified raf-1 
kinase (Bruder and Rapp, unpublished results). Furthermore, it has been stated that 
phorbol esters do not bind to the regulatory domain of raf-1 kinase, but bind strongly to 
PKC (Bruder and Rapp, unpublished results). Although phorbol esters do not bind raf-1 
kinase directly, it has been demonstrated in somatic cells that treatment with the phorbol 
ester 12-0-tetradecanoyl-phorbol-13-acetate (TPA, an activator of PKC) does induce 
activation of raf-1 kinase. Researchers investigated the possible role of PKCa in the 
activation of raf-1 kinase, reaching the conclusion that phosphorylation of Ser499 by 
PKCa is essential, and may be a prerequisite for autophosphorylation of Ser259 and 
subsequent activation of raf-1 kinase (Kolch et al., 1993). 
Based on the results indicating the importance of raf-1 kinase in somatic cell lines, 
researchers have speculated that it may play an important role in germ cells as well. 
Specifically, researchers are investigating the possible role of raf-1 kinase during 
progesterone-induced meiotic maturation in Xenopus oocytes. After progesterone 
stimulation, an increase in raf-1 kinase phosphorylation and enzymatic activity was 
observed concurrently with an elevation in MAP kinase activity. Upon injection of 
mRNA encoding oncogenic raf-1 into nonsteroid-treated oocytes, MAP kinase 
phosphorylation, Hl histone phosphorylation, and germinal vesicle breakdown all took 
place. When oocytes were injected with a dominant negative mutant of raf-1 to block 
endogenous raf-1 kinase activity and then treated with progesterone, none of the events 
mentioned above occurred. mRNA encoding c-mos kinase injected into unstimulated 
oocytes led to phosphorylation of both raf-1 and MAP kinases. Together, all of these 
results lead to the conclusion that raf-1 kinase activity is necessary for progesterone-
induced oocyte meiotic maturation, and that raf-1 kinase is located downstream of c-mos 
kinase within the cascade (Muslin et al., 1993; Fabian et al., 1993). 
It is believed that the only physiological substrate for active raf-1 kinase is MAP 
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kinase kinase. It was shown that MAP kinase kinase was phosphorylated both in vitro as 
well as in vivo by raf-1 kinase (Dent et al., 1992; Huang et al., 1993). Unlike most other 
kinase interactions, raf-1 kinase seems to form a stable complex with MAP kinase kinase, 
with MAP kinase kinase binding to the carboxy-terminal (catalytic) domain of raf-1 
kinase. It has been shown that raf-1 kinase activates MAP kinase kinase by 
phosphorylating two serine residues, Ser217 and Ser221, within the catalytic domain of 
MAP kinase kinase (Alessi et al., 1994). Recently, a group of investigators have shown 
that Cdc25 phosphatase, the activator of Maturation Promoting Factor (MPF, a complex 
of p34cdc2 kinase and cyclin B), associates with raf-1 kinase in somatic mammalian cells 
and in frog meiotic oocytes (Galaktionov et al., 1995). The observed interaction between 
Cdc25 and raf-1 kinase occurred at the carboxy-terminal region of raf-1 kinase in vitro, 
suggesting a strong and specific interaction between the two proteins. 
MAP kinase kinase is a 45 kD protein which was first purified from unfertilized 
Xenopus oocytes (Matsuda et al., 1992). It was named MAP kinase kinase for its ability 
to induce phosphorylation and activation of inactive MAP kinases in vitro. MAP kinase 
kinase is a dual specificity kinase in that it can undergo autophosphorylation on serine, 
threonine, and tyrosine residues (Kosako et al., 1992; Nakielny et al.,1992) and 
phosphorylate MAP kinase on threonine and tyrosine residues (Crews and Erikson, 1992; 
Kosako et al., 1994). No other protein or peptide substrate has yet been identified for 
MAP kinase kinase other than p42/p44 MAP kinases (Wu et al., 1993). Recently, an anti-
Xenopus MAP kinase kinase antibody that specifically inhibits Xenopus MAP kinase 
kinase activity was produced . Microinjection of this antibody inhibited activation of MAP 
kinase by both progesterone stimulation and microinjection of active c-mos kinase in 
Xenopus oocytes. It was also observed that in addition to blocking MAP kinase 
activation, microinjection of the antibody blocked the activation of MPF as judged by 
inhibition of GVBD and histone Hl kinase activation (Kosako et al., 1994). These 
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results strengthen the argument that MAP kinase kinase is responsible for activating MAP 
kinase in vivo, and acts downstream of c-mos kinase within the cascade. 
MAP kinase is a 42kDa serine/threonine protein kinase that is activated in several 
cell types under different conditions. These include initiation of intracellular signaling by 
receptor tyrosine kinases, protein kinase C, or G proteins, which may activate MAP 
kinase by a common pathway, or by pathways that are distinct for each condition (Guan, 
1994; Matsuda et al., 1994). Upon stimulation by the above mentioned agents, MAP 
kinase becomes phosphorylated on both tyrosine and threonine residues and becomes 
activated (Payne et al., 1991). It has further been shown that MAP kinase is activated 
during progesterone-induced oocyte meiotic maturation in Xenopus, and that a kinase 
activated in response to steroid stimulation is capable of phosphorylating MAP kinase on 
tyrosine and threonine residues (Posada and Cooper, 1991). It has been more recently 
shown that this dual phosphorylation event is the result of MAP kinase kinase 
phosphorylating these tyrosine and threonine residues on MAP kinase (Her et al., 1993). 
MAP kinase phosphorylates and regulates numerous cellular signalling proteins. These 
include cell surface proteins, cytoskeletal components, cytoplasmic kinases, and nuclear 
transcription factors. In X enopus oocytes, MAP kinase is able to phosphorylate 
ribosomal S6 kinase II (Sturgill et al., 1988), a protein kinase which will be discussed 
later, and microtubule-associated proteins (MAPs) (Shiina et al., 1992). Several 
researchers have found protein phosphatases that specifically and efficiently 
dephosphorylate, and thereby inactivate, MAP kinases. In vitro, 3CH134, CLlOO, and 
HVHl all appear to function as dual specificity tyrosine/threonine phosphatases that are 
extremely specific for MAP kinases (Nebreda, 1994; Guan, 1994). Further studies need 
to be performed to determine if these phosphatases are responsible for the down-
regulation of MAP kinases in vivo. 
As mentioned previously, one of the physiological substrates for active MAP 
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kinase in Xenopus oocytes, as well as in other cells, is ribosomal protein S6 kinase 
(Pelech et al., 1993). S6 kinase is a 90 kDa protein kinase which, when activated, is 
responsible for the serine phosphorylation of the 40S ribosomal protein S6. Observations 
made in various laboratories indicated that a single ribosomal protein (Mr 32,000) became 
phosphorylated during meiotic maturation in Xenopus oocytes. This protein was 
identified as 40S ribosomal protein S6. It was shown that the level of S6 phosphorylation 
increased throughout maturation, when analyzed by two-dimensional polyacrylamide gel 
electrophoresis (Nielsen et al., 1982; Kruppa et al., 1983; Wasserman and Houle, 1984). 
S6 kinase has been purified fromXenopus oocytes (Erikson and Maller, 1985) and it has 
further been shown that S6 kinase has an extreme substrate specificity for S6, the major 
phosphoprotein of 40S ribosomal subunits (Erikson and Maller, 1986). Results from 
other experiments suggest that the dramatic increase in S6 protein phosphorylation during 
oocyte meiotic maturation may not solely be due to an increase in S6 kinase activity. An 8-
10 fold increase in S6 kinase activity does occur, but in conjunction with this increase, 
there is also a 50% decrease in S6 phosphatase activity, and possibly an increased 
accessibility of the ribosomal substrate to the kinase. All of these changes together may 
play a role in phosphorylation of S6 protein in progesterone-induced meiotic maturation in 
Xenopus oocytes (Wasserman et al., 1988). 
The protein kinase cascade that has been presented is only a partial explanation of 
what is occurring within the oocyte during meiotic maturation. Each kinase most likely 
phosphorylates other substrates in addition to those protein kinases which are located 
directly downstream within the cascade. There also exists the very good possibility that 
there are other kinases within this cascade that have not yet been discovered, but may play 
an important role during meiotic maturation of the oocyte. With regards to my study, I 
have investigated the roles of the five known protein kinases for their possible role in the 
regulation of the Na+/H+ antiporter during Xenopus oocyte meiotic maturation. In 
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addition, I have also tried to determine the site within the protein kinase cascade where 
cAMP blocks the activation of the Na+fH+ anti.porter during oocyte meiotic maturation. 
Experimental Desiim 
CHAPTER II 
MATERIALS AND METHODS 
The Na+/H+ exchangers (NHE = Na+/H+ antiporter) in other cell systems appear 
to be regulated by phosphorylation of the NHE protein. It has already been shown that 
Protein Kinase C, Calcium-Calmodulin Kinase, and Protein Kinase A do not play a role in 
activation of the Na+/H+ antiporter in Xenopus oocytes (Rezai, 1994). During oocyte 
meiotic maturation, progesterone stimulation activates a cascade of protein kinases (Sagata 
et al., 1989). The cascade of protein kinases is as follows. It has been shown that 
progesterone stimulation leads to synthesis of c-mos kinase from stored mRNA (Sagata et 
al., 1989); c-mos kinase is located upstream of raf-1 kinase within the cascade (Muslin et 
al., 1993); raf-1 kinase activates MAP kinase kinase (Huang et al., 1993); MAP kinase 
kinase activates MAP kinase (Kosako et al., 1994); MAP kinase activates S6 kinase 
(Pelech et al., 1993) (see Figure 1). I have concentrated on these five protein kinases for 
their potential role in activating the Na+/H+ antiporter. In Xenopus oocytes, I 
hypothesize that one (or more) of these protein kinases activates the Na+/H+ antiporter by 
a phosphorylation event. 
A) Alternative Hypotheses 
Hypothesis I: 
Hypothesis II: 
c-mos kinase is responsible for activating the Na+/H+ 
anti.porter via a phosphorylation event. 
raf-1 kinase is responsible for activating the Na+/H+ antiporter 
via a phosphorylation event 
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Figure 1. A proposed model of the progesterone-induced protein kinase cascade which 
occurs during Xenopus oocyte maturation. Solid arrows indicate direct activation, 
whereas dashed arrows indicate an indirect activation (based on results from other 
laboratories). 
Hypothesis III: MAP kinase kinase is responsible for activating the Na+/H+ 
anti.porter via a phosphorylation event. 
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Hypothesis IV: MAP kinase is responsible for activating the Na+/H+ anti.porter 
via a phosphorylation event. 
Hypothesis V: S6 kinase is responsible for activating the Na+/H+ antiporter 
via a phosphorylation event. 
Hypothesis VI: An undetermined protein kinase within the cascade is 
responsible for activating the Na+/H+ antiporter via a 
phosphorylation event. 
As there is no antibody available that cross reacts with the Xenopus NHE peptide, 
I was not able to directly investigate whether phosphorylation of the antiporter occurs 
when oocytes were exposed to various treatments. Therefore, I utilized an indirect 
method to observe the involvement of the various protein kinases in regulating the 
antiporter. Protein kinases or mRNA encoding these protein kinases were microinjected 
into stage VI oocytes and the activity of the Na+/H+ anti.porter (changes in pHi) was 
measured. The six possible results are listed below. 
B) Potential Outcomes 
1) If c-mos kinase, in the absence of progesterone, is capable of activating the 
Na+/H+ antiporter without any of the other protein kinases downstream in the 
cascade also being able to do so, then Hypothesis I is supported. 
2) If raf-1 kinase, in the absence of progesterone, is capable of activating the 
Na+/H+ antiporter without any of the other protein kinases downstream in the 
cascade also being able to do so, then Hypothesis II is supported. 
3) If MAP kinase kinase, in the absence of progesterone, is capable of activating 
the Na+fH+ anti.porter without any of the other protein kinases downstream in the 
cascade also being able to do so, then Hypothesis III is supported. 
4) If MAP kinase, in the absence of progesterone, is capable of activating the 
Na+fH+ antiporter without any of the other protein kinases downstream in the 
cascade also being able to do so, then Hypothesis IV is supported. 
5) If S6 kinase, in the absence of progesterone, is capable of activating the 
Na+/H+ antiporter without any of the other protein kinases downstream in the 
cascade also being able to do so, then Hypothesis Vis supported. 
6) If all of the above kinases, in the absence of progesterone are not capable of 
activating the Na+JH+ antiporter, then Hypothesis VI is supported. 
Oocyte Isolation and Culture 
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Ovarian fragments were surgically removed from adult female Xenopus laevis 
(NASCO, Ft. Atkinson, Wisconsin) that had been anesthetized by hypothermia (45 
minutes in ice water). The ovarian fragments were then transferred to OR-2 medium 
(82.3 mM NaCl, 2.5 mM KCl, 1.0 mM CaCh, 1.0 mM MgCJi, 5.0 mM Hepes, 1.0 mM 
Na2HP04, pH 7.6) (Wallace et al., 1973), in which all further procedures were 
performed. Full-grown stage VI oocytes (Dumont, 1972) were removed from the ovarian 
lobes by manually removing the ovarian epithelium and collagen layer with watchmaker's 
forceps, a process known as defolliculation. Collagenase and Pronase were not used to 
digest the follicle cells enzymatically to prevent disruption and damage to cell surface 
proteins as well as the Na+JH+ antiporter (Towle et al., 1991). 
Intracellular pH (pHi) Measurement 
The pHi of the oocytes was determined by using the weak acid, 14C-
Dimethyloxazoladine 2,4 dione, 14C-DMO (NEN) (Wadell and Butler, 1959). In its 
uncharged form, 14C-DMO can pass freely across the oocyte's plasma membrane. Based 
on both the intracellular and extracellular pH environments, a 14C-DMO equilibrium will 
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be formed across the membrane of stage VI oocytes in approximately 2 hours (Houle and 
Wasserman, 1983) (see Figure 2). 
14C-DMO was placed in test tubes at a volume of 2.5 µl per tube (stock 50 
µCi/500 µl), which was then dried under N2 to evaporate the ethyl acetate solvent. In 
each of the pHi experiments, the 14C-DMO was resuspended in 1.0 ml of either OR-2 or 
the desired medium, vortexed, and transferred into 2 ml multiwell plates. The final 
concentration of 14C-DMO in each well was 0.25 µCi/ml. Twenty oocytes were placed 
into each well per treatment, per experiment. After a minimum of 2.5 hours of incubation 
in 14C-DMO at 20° C, drugs or hormones were added and allowed to incubate for the 
desired amount of time at 20° C. 
Upon completion of the given incubation period, both the media and the oocyte 
14C-DMO DPM were determined in triplicate. For the media determination, 10 µl media 
from each treatment were transferred into a scintillation vial along with 10 ml 
Biodegradable Counting Scintillant (BCS, Amhersham) and mixed thoroughly. For the 
oocyte determination, 5 oocytes from each treatment were removed and quickly washed in 
3 consecutive dishes containing non-radioactive OR-2 medium (approximately 5-10 
seconds per dish). The oocytes were then transferred into scintillation vials where any 
excess medium was removed with a pasteur pipette. To each vial was added 0.5 ml NCS-
11 (tissue solubilizer, Amhersham) before they were placed into a 60° C incubator for 35 
minutes where the oocytes were digested. The vials were then placed into a -20° C freezer 
for 10 minutes to cool down, after which 10 ml cold BCS-NA (Non-Aqueous 
Biodegradable Counting Scintillant, Amhersham) were added to each vial, mixed 
thoroughly, and placed into -20° C freezer for another 20 minutes. The media and oocyte 
samples were then counted in a Beckman LS-7000 liquid scintillation counter. The CPM 
data obtained from the counter was converted to DPM, which was then used to determine 






pHi = pKa + log ([DMOJinsicte/[DMO]outside (lQpHo-pKa+ 1)-1) 
= intracellular pH (unknown) 
= pKa of DMO = 6.32 
=concentration ofDMO inside the oocyte 
= DPM/µl (water volume of a stage VI oocyte = 0.45 µl) 
=concentration of DMO outside the oocyte (medium) 
=DPM/µl 
= outside pH = 7 .6 
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There was one basic experimental design that was followed throughout all 
experiments that dealt with regulation of pHj. One group of oocytes was left untreated 
and served as the negative control group; one group was treated with progesterone and 
served as the positive control group; one group of oocytes was microinjected with either 
the desired protein kinase or mRN A encoding the desired protein kinase and served as the 
experimental group. In addition to examining the pH changes in the oocytes, the oocytes 
were also scored for GVBD. All of the experiments were replicated at least three times, 
utilizing oocytes from three different animals on three different days. 
Protein Kinases and Transcription Vectors 
The MBP-c-mos protein fusion protein was obtained from Dr. George F. 
VandeWoude. This construct consists of bacterially expressed active c-mos kinase bound 
to Maltose Binding Protein (MBP), which is eluted from a Maltose-Sepharose column 
with maltose to obtain the purified protein. The protein kinase was in a buffer consisting 





H + + 14C-DMO -
+ 14 
H + C-DMO 
Figure 2. DMO equilibration across the oocyte plasma membrane. Oocytes were 
incubated in 14C-DMO (0.25 µCi/ml) for 2.5 hours at 20°C to allow for equilibration. The 
equilibrium of DMO across the cell membrane was established according to the 
extracellular pH (pHe) and intracellular pH (pHi) environments. 
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stock was 0.95 mg/ml, which was diluted with buffer as needed to concentrations of 1.25 
ng/40 nl to 40.0 ng/40 nl for microinjection into the oocytes. 
MAP kinase kinase was obtained from Dr. Steven Pelech as a bacterial expressed 
glutathione synthetase transferase (GST) -fusion protein that was eluted from GST-
Sepharose beads with glutathione. Three different mutant proteins were received. K97 A 
is a kinase-inactive protein by virtue of a lysine to alanine amino acid substitution that is 
necessary for ATP binding. S218A/S222A is a regulatory double-mutant which is an 
inactive kinase in terms of autophosphorylation and upstream activation. S218E/S222E is 
a regulatory double-mutant which is constitutively active and requires no upstream 
activation. The preparations were dialysed against the following buffer: 200 mM MOPS, 
50 mM EGTA, 20 mM EDTA, 1mMNaC03,10 mM NaF, 240 mM B-glycerophosphate, 
and 50 µMB-methyl aspartic acid. The stock concentration of all three protein kinase 
preparations was 3 µg per 20 µl. 
Active S6 kinase was obtained from Dr. Raymond Erikson as a purified protein 
kinase preparation. The concentration of S6 kinase was 1.22 mg/ml in a buffer consisting 
of 100 mM NaCl, 20 mM Hepes, pH 7.4, and 1.0 mg/ml BSA. The preparation was 
assayed using Xenopus 40s ribosome subunits as substrate. 
Transcription vectors with inserts coding three mutants of raf-1 kinase were 
obtained from Dr. Deborah K. Morrison. The three transcription vectors coded for: wild-
type raf-1 protein (wt-raf-1), which is the full length protein (69 kD) in its 
unphosphorylated form; constitutively active raf-1 protein (.1.N'-raf-1 ), which is just the 
catalytic region of the protein (40 kD) with the regulatory region removed; kinase deficient 
raf-1 protein (KD-raf-1), which is the wt-raf-1 protein (69 kD) with a substitution of 
alanine for serine at position 621 rendering it incapable of kinase activity. The expected 
sizes of the three mRNAs was as follows: wt-raf-1 = 2.2 kilobases, .1.N'-raf-1 = 1.3 
kilobases, and KD-raf-1 = 2.2 kilobases. 
23 
Transcription of Plasmid Vectors 
1. Linearization of Plasmids. Each of the plasmids had to be linearized before it 
could be transcribed into mRNA. All of the plasmids were cut with the restriction enzyme 
EcoR I since there was only one EcoR I restriction site in the plasmid, located downstream 
of the insert. The following protocol was utilized for all of the plasmids. Into a RNase-
free eppendorf tube was added 0.5 µI plasmid solution (approximately 2.0 µg DNA), 2.0 
µl lOx EcoR I Buffer (NEBuffer System, BioLabs, New England), 1.0 µl EcoR I (20 
Units/µ!) (BioLabs, New England), and 16.5 µl RNase-free H10. The solutions were 
placed into a 37° C waterbath for one hour, after which time a 2 µI aliquot was removed 
from each reaction tube and run on a gel to verify proper digestion of the plasmids. The 
remainder of the reaction mixture was precipitated with 1.8 µl 5 M ammonium acetate and 
36 µl 100% ethanol at -20° C. To the 2 µl aliquots were added 3 µl 6x loading buffer 
(0.25% Bromophenol blue, 10 mM Tris-HCl pH 8.0, 1mMEDTA,30% glycerol, dH20 
to 50 ml) and 13 µI RNase-free H20. All samples were heated for ten minutes at 65° C 
and run on an 0.8% agarose gel at 100 volts for 45 minutes. The gel was then stained for 
15 minutes with Ethidium Bromide (EtBr, 0.5 µg/ml), rinsed with RNase-free H10, and 
viewed under an ultraviolet light source comparing the bands of linearized DNA to known 
lambda DNA markers (GIBCO/BRL) run in adjoining lanes. 
2. Transcription of the linearized DNA. The linearized plasmids were centrifuged 
at 12,500 x g for 20 minutes, the supernatant was removed, and the pellets were 
desiccated and resuspended in TE Buffer (10 mM Tris-HCI, 1.0 mM EDTA, pH 8.0). 
The linearized plasmids were transcribed using an in vitro SP6 polymerase transcription 
kit (mMESSAGE mMACHINE Kit, Ambion, Inc.) following the protocol supplied with 
the kit, with the termination step being the following protocol for mRNA purification 
rather than the procedures suggested in the kit. To purify the mRNA that was transcribed, 
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the RNeasy Total RNA Kit following the RNeasy Clean-up Protocol (Qiagen, Inc.) was 
used. The final product was suspended in RNase-free H20. Two separate methods were 
used to determine if the transcription reaction had worked successfully. First, the 
concentration of the mRNA transcribed was determined. Two µl sample were added to 1 
ml RNase-free H20 and the absorbance (A260/ A2so) readings were taken with a 
spectrophotometer. Second, aliquots of the samples were run on an agarose gel to 
determine if the proper size mRN A was transcribed. All samples were first denatured in 
the following solution: 4.7 µI mRNA (2 µg). 2.0 µl 5x MOPS, 3.3 µl formaldehyde, 
10.0 µl formamide, and 1.5 µl EtBr (stock = 10 mg/ml) for 15 minutes at 55° C, after 
which 5 µl of 6x loading buffer (same buffer as was used in DNA agarose gels) was 
added. The samples were then run on a 1.0% agarose gel containing lx MOPS and 0.67 
M formaldehyde at 70 volts for 45 minutes. The gel was then thoroughly rinsed with 
RNase-free H20 (approximately 30 minutes, changing it periodically) and viewed on an 
ultraviolet light source. The sizes of the transcripts were compared to RNA markers 
(Promega) run in adjoining lanes. 
Microinjection of Protein Kinases and mRNA 
Throughout my study, I used either protein kinases or mRNA encoding protein 
kinases that would not readily pass across the plasma membrane of the oocyte and 
therefore had to be microinjected directly into the oocyte cytoplasm. Microinjection 
needles were made from 10 mm x 100 mm glass capillary tubes using a De-Fonbrune 
microforge, and were designed to deliver 1.25 ng to 40.0 ng per 40 nl per oocyte. This 
delivery was made into a single site within each oocyte's cytoplasm. A Brinkman 
micromanipulator was used to guide the injection needles. 
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Electrophoretic Analysis of Raf-1 Protein Products 
To examine the raf-1 kinase proteins synthesized in mRNA-injected oocytes, 10 
stage VI oocytes were left untreated, treated with progesterone (1 µM, Sigma), or 
microinjected with mRNA for the three forms of raf-1 kinase and allowed to incubate for 6 
hours at 20° C. The oocytes were then labelled in 35S-methionine at 50 µCi/ml for 1 hour 
at 20° C. After the 1 hour of labelling, 6 oocytes from each treatment group were 
homogenized in 1.0 ml protein extraction homogenization buffer (100 mM NaCl, 20 mM 
Tris-HCl, 10 mM B-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride) and 
centrifuged for 10 minutes at 12,500 x g. After centrifugation, 0.5 ml supernatant was 
drawn off and added to 1.0 ml 100% ethanol and stored at -20° C for a minimum of 8 
hours to precipitate proteins. 
The precipitates were then centrifuged for 20 minutes at 12,500 x g, the 
supernatant was removed, and the protein pellets were dried for 1 hour under vaccum. 
The pellets were resuspended in 50 µl SDS sample buffer (Tris, pH 6.8, glycerol, 
bromphenol blue, B-mercaptoethanol, sodium dodecyl sulfate, and dH20), boiled, and 
then loaded onto a 10% Laemmli gel (1970). After running at 25 milliamps for 3.5 hours, 
the gel was stained with Coomassie Blue to confirm that equal amounts of protein were 
present in each lane. The gel was then subjected to flurography with 2,5-Diphenyloxazole 
(PPO) and glacial acetic acid, dried for 2 hours at 80° C, and put up with XAR-5 film 
(Kodak) and stored at -85° C for 3 days. After film development, the newly synthesized 
raf-1 kinase protein bands were compared to 14C-marker proteins (Amersham) that were 
run in separate lanes. 
Dose Response Curves for Protein Kinases or mRNA 
Preliminary experiments consisted of microinjecting the stock concentration of the 
protein or mRNA into stage VI oocytes and determining if a statistically significant 
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increase in pHi had occurred compared to control and progesterone-treated oocytes. All 
preliminary experiments were replicated at least three times for each protein or mRNA. If 
a significant increase in pHi was observed, the following experiments were carried out 
Groups of 20 stage VI oocytes were microinjected with different doses of the 
protein kinase or mRNA ranging from 1.25 ng to 40.0 ng per oocyte and were incubated 
in OR-2 media containing 14C-DMO at 20° C for the times indicated in the text. After this 
incubation period, the oocyte pHi was determined for the various doses and compared to 
the pHi in control and progesterone-treated oocytes. The lowest dose of protein or 
mRNA which gave a pHi increase that was statistically similar to the pHi of progesterone-
treated oocytes was used in all subsequent experiments . 
Protein Synthesis Requirement for Antiporter Activation 
It has been shown that protein synthesis is necessary for GVBD to occur in 
response to progesterone treatment (Wasserman and Masui, 1975). It has also been 
shown that a new protein(s) has to be synthesized in order to activate the Na+/H+ 
antiporter in response to progesterone stimulation (Rezai, 1994). It is known that c-mos 
kinase is newly synthesized upon hormonal stimulation (Sagata et al., 1989), but is c-mos 
kinase the only newly synthesized protein needed to activate the Na+JH+ anti.porter? 
Groups of 20 stage VI oocytes were preincubated in OR-2 medium containing 
14C-DMO with or without cycloheximide (10 µg/ml, Sigma), a specific inhibitor of 
protein synthesis for 12 to 14 hours. This concentration of cycloheximide has been 
shown to inhibit protein synthesis by 98% (Wasserman et al., 1986). The oocytes were 
then either left untreated, treated with progesterone (1 µM, Sigma), or microinjected with 
a particular protein kinase and allowed to incubate at 20° C for 8 to 12 hours. After this 
incubation period, the oocyte pHi was determined for all treatment groups. The protein-
microinjected groups were compared to the control and progesterone-treated groups in the 
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absence or presence of cycloheximide. 
The Effect of cAMP on Antiporter Activation 
It has been shown that progesterone has an inhibitory effect on adenylate cyclase 
inXenopus oocytes causing a decrease in oocyte cAMP levels (Maller and Krebs, 1977; 
Schorderet-Slatkine et al., 1982; Matten et al., 1994). It has also been shown that if 
intracellular cAMP concentrations remain elevated, progesterone-induced GVBD will not 
occur (Schorderet-Slatkine et al., 198 2). Recent studies by Rezai ( 1994) have indicated 
that elevated levels of cAMP are also antagonistic toward progesterone-induced activation 
of the Na+JH+ antiporter. My goal was to determine at what point within the protein 
kinase cascade elevated levels of intracellular cAMP inhibit activation of the Na+/H+ 
antiporter. Previous studies have shown that there are at least two different experimental 
methods of altering cAMP levels in Xenopus oocytes: forskolin, an activator of adenylate 
cyclase; and 8-Bromo-adenosine-3':5'-monophosphate, cyclic (8-Br-cAMP), a cell-
permeable cAMP analogue. 
1. Forskolin. Groups of 20 stage VI oocytes were preincubated in OR-2 medium 
containing 14C-DMO with or without forskolin (100 µM, Calbiochem) for 8 to 14 hours 
at 20° C. This concentration of forskolin as well as the incubation period were selected 
based on previous studies (Rezai, 1994). The oocytes were then either left untreated, 
treated with progesterone (1 µM, Sigma), or rnicroinjected with a particular protein kinase 
or mRNA and allowed to incubate at 20° C for the times indicated in the text. After this 
incubation period, the oocyte pHi was determined for all treatment groups. 
2. 8-Br-cAMP. Groups of 20 stage VI oocytes were preincubated in OR-2 
medium containing 14C-DMO with or without 8-Br-cAMP (1.0 mM, Boehringer 
Mannheim) for 8 to 14 hours at 20· C. This concentration of 8-Br-cAMP was selected 
based on other studies (Nagasaka et al., 1994). The oocytes were then either left 
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untreated, treated with progesterone (1 µM, Sigma), or rnicroinjected with a particular 
protein kinase or mRNA and allowed to incubate at 20° C for the times indicated in the 
text. After this incubation period, the oocyte pHi was determined for all treatment groups. 
Electrophoretic Analysis of S6 Phosphorylation in MAP Kinase Kinase or S6 Kinase 
Injected Oocytes 
To verify that active MAP kinase kinase and S6 kinase were being rnicroinjected 
into the oocytes, the phosphorylation of the S6 protein on the 40s ribosomal subunit was 
monitored since the cascade follows from MAP kinase kinase to MAP kinase to S6 kinase 
to the phosphorylation of the S6 protein. To examine ribosomal S6 protein 
phosphorylation, 10 stage VI oocytes were left untreated, treated with progesterone (1 
µM, Sigma), or rnicroinjected with MAP kinase kinase (which was concentrated 3-fold 
with centricon 30 microconcentrators, Micon) or S6 kinase, labelled in 32p_ 
orthophosphate at 50 µCi/ ml for 8 to 12 hours at 20° C. After this incubation, oocytes 
were homogenized, protein was extracted and precipitated as mentioned previously. The 
precipitated proteins were resuspended and run on a gel, checked for equal loading of 
proteins, and dried as described above without flurography. The dried gel, XAR-5 film 
(Kodak), and an intensification screen were then stored at -85° C for 3 days. After film 
development, the phosphorylated ribosomal S6 protein bands were compared in the 
various treatment groups. 
Statistical Analysis 
In each experiment, three groups of five oocytes each (15 oocytes total) were used 
to measure the intracellular pH of the oocyte in triplicate. All experiments were replicated 
using oocytes from a minimum of three different animals on three different days (n = 3). 
All intracellular pH values are the mean pHi value ±the standard error of the mean. The 
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data were analyzed by two-way analysis of variance (ANOV A), and when a significant F-
value was encountered, the different treatments were compared using the Tukey's multiple 




The order of the following experiments reflects the order in which the various 
protein kinases were received from other Laboratories. 
Part I: c-mos kinase 
The first protein kinase to be investigated in this study was c-mos kinase. A 
previous study from our laboratory has implicated c-mos kinase in activation of the 
Na+/H+ antiporter in Xenopus oocytes during meiotic maturation (Rezai, 1994). 
Preliminary results using high doses of kinase microinjected into oocytes indicated that 
either c-mos kinase, or some protein kinase downstream of c-mos kinase played a role in 
the activation of the Na+/H+ antiporter. The focus of my initial experiments was to 
confirm the role of c-mos kinase in regulation of oocyte pHi during progesterone-induced 
meiotic maturation. 
A. c-mos kinase Dose Response Curve: 
Injecting 20 ng c-mos protein per oocyte induced an increase in oocyte pHi that 
was statistically similar to the increase in pHi caused by progesterone (Rezai, 1994). To 
determine the lowest concentration of c-mos protein needed to cause an increase in oocyte 
pHi that was similar to the increase in pHi caused by progesterone, oocytes were injected 
with different concentrations of c-mos protein. As shown in Figure 3, oocytes were 
microinjected with concentrations of c-mos kinase ranging from 1.25 ng to 40.0 ng per 
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Figure 3. c-mos kinase dose response curve. Oocytes were either left untreated (cont), 
treated with progesterone (1 µM), or microinjected with concentrations of c-mos kinase 
ranging from 1.25 to 40.0 ng of protein per oocyte. At concentrations of 5.0 ng per 
oocyte and higher, the increase in pHi was statistically similar to the increase in pHi 
induced by progesterone. All subsequent experiments used 5.0 ng of c-mos protein per 
oocyte. Columns with different letters above them are significantly different from each 
other using Tukey's multiple test comparison. The data are expressed as means ± the 
standard error of the mean, where n=3. 
32 
which appeared to level off at concentrations greater than 5.0 ng protein per oocyte. 5.0 
ng c-mos protein was the lowest concentration that caused an increase in oocyte pHi 
statistically similar to the increase in oocyte pHi induced by progesterone. All subsequent 
experiments used 5.0 ng c-mos protein per oocyte. 
B. Protein Synthesis ReQllirement for N ~ Antiporter Activation: 
It has been shown that oocyte protein synthesis is required for activation of the 
Na+fH+ antiporter in response to progesterone stimulation (Rezai, 1994). It is known that 
c-mos kinase is newly synthesized upon hormonal stimulation (Sagata et al., 1989). To 
determine if c-mos kinase is the only newly synthesized protein required for the activation 
the Na+JH+ antiporter during oocyte meiotic maturation, the following experiment was 
performed. Oocytes were treated either with 10 µg/ml cycloheximide (a specific inhibitor 
of protein synthesis, at a concentration which has been shown to inhibit protein synthesis 
by 98%, Wasserman et al., 1986) and 14C-DMO or just with 14C-DMO for 12 to 14 
hours. As shown in Figure 4, oocytes from each of the two groups were either left 
untreated (Cont), treated with progesterone (1 µM), or microinjected with c-mos protein 
(5 ng/oocyte). The results showed that the pHi in steroid-stimulated oocytes treated with 
cycloheximide remained at levels that were statistically similar to the pHi of both control 
oocytes with or without cycloheximide. The results showed that the pHi of oocytes 
microinjected with c-mos protein, even in the presence of cycloheximide, was statistically 
similar to the pHi of progesterone-stimulated oocytes. Thus, c-mos kinase appears to be 
the only newly synthesized protein needed for the activation of the Na+fH+ antiporter 
during oocyte meiotic maturation. 
C. cAMP Block of Antiporrer Activation: 
Progesterone has been shown to have an inhibitory effect on adenylate cyclase in 
Xenopus oocytes causing a decrease in oocyte cAMP levels (Sadler and Maller, 1981). 
Not only has it been demonstrated that eleYated cAMP concentrations within the oocyte 
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Figure 4. c-mos kinase is the only newly synthesized protein needed for activation of the 
Na+/H+ antiporter. Oocytes were incubated in 14C-DMO for 12 to 14 hours in the presence 
or absence of cycloheximide (10 µg/ml). The oocytes from both groups were the either left 
untreated (Cont.), treated with progesterone ( 1 µM), or microinjected with c-mos kinase 
(5.0 ng/oocyte). The pHi of oocytes nTicroinjected with c-mos kinase, both treated and not 
treated with cycloheximide, was statistically similar to the pHi of progesterone-treated 
oocytes that had not been treated with cycloheximide. Columns with different letters above 
them are significantly different from each other using Tukey's multiple comparison test. 
The data are expressed as means ± the standard error of the mean, where n=3. 
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inhibit GVBD (Schorderet-Slatk:ine et al., 1982), but a recent study from our laboratory 
has indicated that elevated levels of cAMP are also antagonistic toward progesterone-
induced activation of the Na+JH+ antiporter during oocyte meiotic maturation (Rezai, 
1994). To determine if elevated levels of intracellular cAMP are antagonistic toward c-
mos kinase-induced activation of the Na+/H+ antiporter, the following two methods of 
altering cAMP levels in Xenopus oocytes where used. 
1. Forskolin Activation of Acienylate Cyclase: 
The first method used was incubating the oocytes in forskolin, an activator of 
adenylate cyclase, to elevate the levels of intracellular cAMP. Oocytes were treated either 
with forskolin (100 µM) at a concentration shown to have an inhibitory effect on the 
progesterone-induced increase in pHi (Rezai, 1994) in 14C-DMO, or just with 14C-DMO 
for 12 to 14 hours. Oocytes from each of the two groups were left untreated (Cont.), 
treated with progesterone (1 µM), or microinjected with c-mos protein (5 ng/oocyte). As 
shown in Figure 5, forskolin inhibited the increase in pHi in progesterone-stimulated 
oocytes to a level that was statistically similar to control pHi levels. Forskolin did not 
appear to be antagonistic to c-mos kinase's ability to activate the Na+JH+ antiporter. The 
pHiS in c-mos kinase-injected oocytes with or without forskolin pretreatment were 
statistically similar. 
2. 8-Br-cAMP Elevation of Intracellular cAMP Levels: 
To verify the forskolin results, a second method of elevating levels of intracellular 
cAMP was utilized. 8-Br-cAMP (8-Bromo-adenosine-3':5'-monophosphate, cyclic) is a 
cAMP derivative capable of passing through the oocyte's membrane into the cytoplasm, 
thus causing an elevation in intracellular cAMP levels. Oocytes were treated with 8-Br-
cAMP (1.0 mM) in 14C-DMO or just with 14C-DMO for 12 to 14 hours. Oocytes from 
each of the two groups were either left untreated (Cont.), treated with progesterone (1 
µM), or microinjected with c-mos protein (5 ng/oocyte). As shownin Figure 6, 
35 
8.0 
• - Forskolin 7.9 • + Forskolin b 7.8 
7.7 
7.6 






Cont. Prog. c-mos 
Figure 5. Forskolin does not appear to be antagonistic to c-mos kinase's ability to activate 
the Na+/H+ antiporter. Oocytes were incubated in 14C-DMO for 12 to 14 hours in the 
presence or absence of forskolin (100 µM). The oocytes from both groups were then 
either left untreated (Cont.), treated with progesterone (1 µM), or microinjected with c-
mos kinase (5.0 ng/oocyte). The pHi of the oocytes microinjected with c-mos did not 
differ significantly regardless if treated with forskolin or not. Columns with different 
letters above them are significantly different from each other using Tukey's multiple 
comparison test. The data are expressed as means± the standard error of the mean, where 
n=4. 
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8-Br-cAMP was antagonistic to progesterone's ability to cause an increase in pHi, 
maintaining pHi at levels statistically similar to the control pHi values. The results with c-
mos kinase and 8-Br-cAMP confirmed the results of the forskolin experiment. Oocytes 
injected with c-mos kinase and treated with 8-Br-cAMP maintained levels of elevated pHi 
that were statistically similar to the group of oocytes that was just stimulated with 
progesterone. The results from both the forskolin experiments and the 8-Br-cAMP 
experiments showed that elevated levels of intracellular cAMP were antagonistic toward a 
progesterone-induced increase in pHi but have no effect on the ability of c-mos kinase to 
cause an increase in pHi. This indicates that the cAMP block is downstream of the 
progesterone receptor, but upstream of c-mos kinase in the protein kinase cascade. 
Part II: S6 kinase 
S6 kinase was the next protein kinase investigated. S6 kinase, when activated, is 
responsible for phosphorylating the 40S ribosomal protein S6. S6 kinase is one of the 
terminal kinases, located directly downstream of MAP kinase. It has further been shown 
that the substrate of S6 kinase, 40S ribosomal protein S6, becomes phosphorylated during 
oocyte meiotic maturation. I therefore wanted to investigate if S6 kinase, in addition to 
phosphorylating the ribosomal protein, was involved in regulation of the Na+/H+ 
antiporter during oocyte meiotic maturation. 
A. S6 kinase Effect on pHj; 
To determine if S6 kinase is involved in activating the Na+fH+ antiporter, groups 
of oocytes were preincubated in 14C-DMO for 12 to 14 hours, and then were either left 
untreated (Cont.), treated with progesterone (1 µM). or microinjected with active S6 
kinase (50 ng/oocyte). As shown in Figure 7, oocytes injected with active S6 kinase did 
not exhibit an increase in pHi. Oocytes injected with S6 kinase maintained pHi levels that 
were statistically similar to those in untreated oocytes. 
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Figure 6. Elevating intracellular levels of cAMP with 8-Br-cAMP does not appear to be 
antagonistic to c-mos kinase's ability to activate the Na+/H+ antiporter. Oocytes were 
incubated in 14C-DMO for 12 to 14 hours in the presence or absence of 8-Br-cAMP (1.0 
mM). The oocytes from both groups were then either left untreated (Cont.), treated with 
progesterone (1 µM), or microinjected with c-mos kinase (5.0 ng/oocyte). The pHi of 
oocytes microinjected with c-mos kinase, both treated and not treated with 8-Br-cAMP, 
were statistically similar to one another, as well as to the pHi of progesterone-treated 
oocytes not treated with 8-Br-cAMP. Columns with different letters above them are 
significantly different from each other using Tukey's multiple comparison test. The data 
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Figure 7. S6 kinase does not activate the Na+/H+ antiporter. Oocytes were incubated in 
14C-DMO for 12 to 14 hours and were then either left untreated (Cont.), treated with 
progesterone (1 µM), or microinjected with S6 kinase (50 ngloocyte). The pHi of the 
oocytes microinjected with S6 kinase was statistically different from the pHi of the 
progesterone-treated oocytes, but statistically similar to the pHi of oocytes that were left 
untreated (Cont.). Columns with different letters above them are significantly different 
from each other using Tukey's multiple comparison test The data are presented as means 
± the standard error of the mean, where n=4. 
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B. Electrophoretic Analysis of S6 Phosphorylation: 
The above result indicated that S6 kinase does not play a role in regulating pHi. 
To verify that the injected S6 kinase was active, phosphorylation of S6 protein in the 
injected oocyte ribosomal subunits was monitored. Oocytes were either left untreated 
(Cont.), stimulated with progesterone (l µM), or microinjected with S6 kinase and 
labelled in OR-2 medium with 32P-orthophosphate (100 µCi/ml) for 8 hours. Oocytes 
were removed from their respective treatments and proteins were extracted and 
electrophoresed using a SDS-polyacrylamide gel (SDS-PAGE). Figure 8 shows an 
autoradiograph comparing the phosphorylation of S6 protein between the three treatments. 
S6 protein has a molecular weight of 32,000. Based on this experiment, S6 protein 
(32,000 Da) was phosphorylated in the progesterone-stimulated oocytes as well as in the 
S6 kinase-microinjected oocytes, but not in the untreated oocytes. This indicates that the 
S6 kinase that was used in previous experiments was active and that the negative effect of 
S6 kinase on oocyte pHi was valid. 
Part III: raf-1 kinase 
I was unable to obtain raf-1 kinase protein, but rather, received transcription 
vectors with inserts coding for three forms of raf-1 kinase. The three transcription vectors 
coded for: l) wild-type raf-1 protein (wt-raf-1), the full length protein in its 
unphosphorylated form; 2) constitutively active raf-1 protein (~'-raf-1 ), just the catalytic 
region of the protein with the regulatory region removed; 3) kinase deficient raf-1 protein 
(KD-raf-1), the wt-raf-1 protein with an alanine for serine substitution at position 621 
rendering it incapable of kinase activity (Fabian et al., 1993). 
A. Transcription of Plasmid Vectors and Translation of mRN A for raf-1: 
1. Linearization of raf-1 Plasmids: 






Figure 8. S6 kinase phosphorylates the S6 protein when injected into oocytes. Oocytes 
were left either untreated (lane 1), treated with progesterone (1 µM) (lane 2), or 
microinjected with S6 kinase (lane 3) and labelled in OR-2 medium with 32p_ 
orthophosphate (100 µCi/ml) for 8 hours. Protein was extracted from each of the 
treatment groups and run on a 10% SDS-polyacrylamide gel. Phosphorylation of the S6 
protein (32,000 Da) was observed in both the progesterone-treated oocytes, as well as in 
the S6 kinase microinjected oocytes, but not in the untreated oocytes as compared with 
14C-methylated protein markers (lane not shown). 
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mRNA. The plasmids were cut with the restriction enzyme EcoR I. There was only one 
EcoR I restriction site in each of the plasmids, located not too far downstream of the 
inserts. After the digest, a sample of each DNA product was electrophoresed on a 0.8% 
agarose gel to verify that the plasmids were cut only once, and that the linearized 
fragments were of the proper length. Figure 9 is a photograph of an ethidium bromide-
stained agarose gel which has alternating lanes of uncut and cut plasmids. Lanes at both 
ends of the gel are lambda DNA markers. As seen in figure 9, the uncut plasmid existed 
as both a supercoiled and a relaxed form, while the digest produced a single DNA 
fragment of 4.8, 4.8, and 4.3 kilobases in length for wt-raf-1, KD-raf-1 and iiN'-raf-1 
respectively. 
2. Transcription of the Linearized raf-1 DNA: 
The linearized DNA for all three plasmids was transcribed using an in vitro SP6 
polymerase transcription kit (Ambion). In order to purify the transcribed mRNA, RNeasy 
centrifuge columns were used and the final product was suspended in RNase-free H20. 
To ensure that the transcription product mRNA was of the proper length, 2.0 µg of each 
mRNA sample was run on a 1.0% agarose denaturing gel. Figure 10 shows a photograph 
of an ethidium bromide-stained gel with two lanes of each mRNA sample flanked by 
known RNA markers. As seen in figure 10, the sizes of the transcribed mRNA were 2.2 
kilobases for the wt-raf-1 and KD-raf-1 mRNAs, and 1.7 kilobases for the iiN'-raf-1 
mRNA coding just for the catalytic region of the protein. These transcript sizes agree with 
published values. 
3. Electrophoretic Analysis of raf-1 mRNA Translation Products: 
The transcribed mRNA coding for the three forms of raf-1 kinase were 
microinjected into different groups of oocytes. H the oocytes were capable of translating 
the mRNA, then the possible effects of these protein products on pHi could be monitored 
after microinjecting the mRNA samples. To confirm that the microinjected mRNAs were 
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Figure 9. Linearization of raf-1 DNA plasmids. Each of three plasmids were cut with 
the restriction enzyme EcoR I to linearize them for transcription. Samples from each 
digest were run on a 0.8% agarose gel and stained with ethidium bromide. Lanes 1 and 
8: lambda DNA markers; lane 2: uncut wt-raf-1; lane 3: cut wt-raf-1; lane 4: uncut ~N'­
raf-1; lane 5: cut ~'-raf-1; lane 6: uncut KD-raf-1; lane 7: cut KD-raf-1. The two bands 
appearing in all of the uncut lanes represent both the supercoiled (lower band) and relaxed 
(upper band) forms of the plasmid. 
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Figure 10. Transcription of the linearized raf-1 DNA. The three linearized plasmids were 
transcribed using an in vitro SP6 transcription kit, and purified using RN easy centrifuge 
columns. The transcription products were run on a 1.0% agarose denaturing gel and 
stained with ethidium bromide. Lanes 1 and 8: RNA markers; lanes 2 and 3: wt-raf-1 
; 
mRNA; l~es 4 ~d 5: Llli( raf-1 IDRNA;~ lanes &-and ? :'· Kn-raf-1 mRNA. 
44 
translated in vivo, three different groups of oocytes were microinjected with a given 
mRNA, labelled with 35S-methionine, and then homogenized and the protein extracted. 
The protein extracts were electrophoresed on SOS-PAGE and the final results were 
viewed via autoradiography techniques. Figure 11 is an autoradiograph of newly 
synthesized protein made in mRNA-injected oocytes, as well as in a control group of 
oocytes that were microinjected with RNase-free H20. From this autoradiograph it is 
evident that the oocytes are translating the microinjected mRNA as is observed by the 
definitive dark bands found in the three treatment lanes and not in the control lane. These 
bands correspond to the published molecular weights, with wt-raf-1 kinase and KD-raf-1 
kinase appearing as proteins of similar size (69 kDa), and ~'-raf-1 kinase appearing as a 
smaller protein (40 kDa) which was expected, as it is just the catalytic region of the protein 
and not the full-length protein. 
B. pHi Measurement in ra[-1 mRNA-injected Oocytes: 
1. Oocyte plii for mRNA-injected Oocytes: 
Oocytes were preincubated in 14C-DMO for 12 to 14 hours. As shown in Figure 
12, oocytes were either left untreated, treated with progesterone (1 µM), or microinjected 
with stock concentrations of the three raf-1 mRN A products. Oocytes rnicroinjected with 
wt-raf-1 and KD-raf-1 mRNAs coding for inactive proteins did not exhibit an increase in 
pHi. Oocytes rnicroinjected with AN'-raf-1 mRNA coding for an active kinase did exhibit 
an increase in pHi that appeared similar to the increase in pHi caused by progesterone 
stimulation. Based on this unreplicated experiment, it appeared that active AN'-raf-1 
caused an increase in pHi. Therefore, the role of active raf-1 kinase was investigated 
further. 
2. AN'-raf-1 mRNA Dose Response CuIYe: 
Oocytes were injected with different concentrations of AN'-raf-1 mRNA, to 
determine the lowest concentration of mRNA needed to induce an increase in oocyte pHi 
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Figure 11. Electrophoretic analysis of raf-1 mRNA translation in vivo. Oocytes were 
microinjected with either H20 (lane 1) as a control, wt-raf-1 mRNA (lane 2), ~N'-raf-1 
mRNA (lane 3), or KD-raf-1(lane4) and labelled in OR-2 media with 35S-methionine. 
Protein was then extracted and run on a 10% SDS-polyacrylamide gel. The microinjected 
mRNA was successfully translated by the oocyte (wt-raf-1 and KD-raf-1 = 69 kDa; m·-
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Figure 12. The effects of the three raf-1 mRNAs on oocyte pHj. Oocytes were either left 
untreated (Cont.), treated with progesterone (1 µM), ormicroinjected with one of the three 
raf-1 mRNAs. Only the AN'-raf-1 mRNA caused an increase in oocyte pHi as well as 
GVBD (numbers above the bars show number of oocytes that underwent GVBD out of 20 
oocytes). 
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that was similar to the increase in pHi induced by progesterone. As shown in Figure 13, 
oocytes were microinjected with concentrations of ~N'-raf-1 mRNA ranging from 1.25 
ng to 10.0 ng per oocyte. The oocytes were then incubated for 12 to 14 hours to allow for 
translation of the mRNA. The results indicated that increasing concentrations of ~N'-raf-
1 mRNA (and presumably raf-1 protein) induced higher levels of pHi. which appeared to 
level off at concentrations greater than 2.5 ng of mRNA per oocyte. Based on these 
results, 5.0 ng AN'-raf-1 mRNA per oocyte was the lowest concentration of mRNA that 
consistently induced an increase in oocyte pHi that was statistically similar to the increase 
in pHi induced by progesterone. All subsequent experiments were conducted using 5.0 
ng AN'-raf-1 mRNA per oocyte. 
C. The Effect of cAMP on raf-1 Reirulation of the Na±fil± Antiporter: 
Recent studies have indicated that elevated levels of cAMP are antagonistic toward 
progesterone-induced activation of the Na+/H+ antiporter during oocyte meiotic maturation 
(Rezai, 1994). To determine if elevated levels of intracellular cAMP are also antagonistic 
toward raf-1 kinase-induced activation of the Na+/H+ antiporter, the following 
experiments altering cAMP levels in Xenopus oocytes were performed. 
1. Forskolin Activation of Adenylate Cyclase: 
Oocytes were treated with forskolin (100 µM) in 14C-DMO or only with 14C-
DMO for 8 hours. As shown in Figure 14, oocytes from each of the two groups were left 
untreated (Cont.), treated with progesterone (l µM), or microinjected with AN'-raf-1 
mRNA (5.0 ng/oocyte) and incubated for 12 to 14 hours. The results show that forskolin 
significantly inhibited the increase in pHi in progesterone-stimulated oocytes. Forskolin 
did not appear to be antagonistic to ~N'-raf-l's ability to activate the Na+JH+ antiporter. 
The pHi in AN'-raf-1 mRNA injected oocytes pre-treated with forskolin was statistically 
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Figure 13. AN'-raf-1 mRNA dose response curve. Oocytes were either left untreated 
(Cont.), treated with progesterone (1 µM), or microinjected with concentrations of AN'-
raf-1 mRNA ranging from 1.25 to 10.0 ng of mRNA per oocyte. At concentrations of 
2.5 ng mRNA per oocyte and higher, the increase in pHi was statistically similar to the 
increase in pHi induced by progesterone. Columns with different letters above them are 
significantly different from each other using Tulcey's multiple comparison test. The data 
are expressed as means± the standard error of the mean, where n=3. 
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Figure 14. Forskolin does not appear to be antagonistic to AN'-raf-1 's ability to activate 
the Na+/H+ antiporter. Oocytes were incubated in 14C-DMO for 8 hours in the presence 
or absence of forskolin (100 µM). The oocytes from both groups were then left untreated 
(Cont.), treated with progesterone (1 µM), or microinjected with AN'-raf-1 mRNA (5.0 
ng/oocyte). Forskolin treatment significantly blocked the ability of progesterone to 
activate the antiporter. The pHi of the oocytes microinjected with the AN'-raf-1 mRNA 
did not differ significantly from one another whether they were treated with forskolin or 
not. Columns with different letters above them are significantly different from each other 
using Tukey's multiple comparison test. The data are presented as means± the standard 
error of the mean, where n=3. 
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2. 8-Br-cAMP Elevation of Intracellular cAMP Levels: 
To verify the forskolin results. a second method of elevating levels of intracellular 
cAMP was utilized. Oocytes were treated with 8-Br-cAMP (1.0 mM) in 14C-DMO or 
only in 14C-DMO for 8 hours. As shown in Figure 15, oocytes from each of the two 
groups were left untreated (Cont.), treated with progesterone (1 µM), or microinjected 
with ti.N'-raf-1 mRNA (5.0 ng/oocyte) and incubated for 12 to 14 hours. The results 
indicate that 8-Br-cAMP was antagonistic to progesterone's ability to induce an increase in 
pHi, but had no significant effect on ti.N'-raf-1 mRNA injected oocytes. These results 
confirmed the forskolin experiments. The results from both the forskolin experiments and 
the 8-Br-cAMP experiments show that elevated levels of intracellular cAMP are 
antagonistic toward a progesterone-induced increase in pHi but have no effect on the 
ability of raf-1 kinase to cause an increase in pHj. Therefore, it appears that the cAMP 
block is downstream of the progesterone receptor, but upstream of raf-1 kinase in the 
protein kinase cascade. 
Part IV: MAP kinase kinase 
MAP (Mitogen Activated Protein) kinase kinase was the next kinase to be 
investigated for its possible role in activation of the Na+/H+ antiporter. This kinase is a 
substrate for raf-1 kinase within the protein kinase cascade. as well as the activator of 
MAP kinase which is located downstream of MAP kinase kinase within the cascade. To 
determine if MAP kinase kinase was responsible for inducing the increase in the oocyte 
pHi, the following experiments were conducted. 
A. pHi Measurement in MAP klnase kinase Injected Oocytes: 
Groups of oocytes were preincubated in 14C-DMO for 3 to 4 hours. As shown in 
Figure 16, oocytes were left untreated, treated with progesterone (1 µM), or microinjected 
with constitutively active MAP kinase kinase (6.0 ngfoocyte). The oocytes microinjected 
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Figure 15. Elevating levels of intracellular cAMP with 8-Br-cAMP does not appear to be 
antagonistic to the ability of AN'-raf-1 to activate the Na+/H+ antiporter. Oocytes were 
incubated in 14C-DMO for 8 hours in the presence or absence of 8-Br-cAMP (1.0 mM). 
The oocytes from both groups were left untreated (Cont.). treated with progesterone (1 
µM), or microinjected with AN'-raf-1 mRNA (5.0 ngfoocyte). 8-Br-cAMP significantly 
blocked the ability of progesterone to activate the antiporter. The pHi of the oocytes 
microinjected with the AN'-raf-1 mRNA did not differ from one another significantly 
whether treated with 8-Br-cAMP or not. Columns with different letters above them are 
significantly different from each other using Tukey's multiple comparison test. The data 
are presented as means± the standard error of the mean, where n=4. 
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with constitutively active MAP kinase kinase did not exhibit an increase in pHi as did 
those oocytes which were stimulated with progesterone. Oocytes microinjected with 
constitutively active MAP kinase kinase maintained levels of pHi that were statistically 
similar to the pHi levels found in untreated oocytes (Figure 16). 
B. S6 Phos.phorylation as a Confirmation of MAP kinase kinase Activity: 
The previous results indicated that constitutively active MAP kinase kinase did not 
cause any significant increase in pHi. It has been shown that active MAP kinase kinase 
activates MAP kinase, which in tum activates S6 kinase in the protein kinase cascade. To 
verify that the MAP kinase kinase microinjected into the oocytes was active, 
phosphorylation of the S6 protein on the 40S ribosomal subunit was monitored. Oocytes 
were left untreated (Cont.), stimulated with progesterone (1 µM), or microinjected with 
constitutively active MAP kinase kinase and labelled in OR-2 medium with 32p_ 
orthophosphate (100 µCi/ml) for 12 to 14 hours. Oocytes were removed from their 
respective treatments and proteins were extracted and run on a SDS-polyacrylamide gel. 
Figure 17 shows an autoradiograph comparing the phosphorylation of S6 protein between 
the three treatments. S6 protein has a molecular weight of 32,000 Da (14C-methylated 
protein markers: lysozyme (14,300 Da), carbonic anhydrase (30,000 Da), ovalbumin 
(46,000 Da), bovine serum albumin (69,000 Da), and phosphorylase b (97,400 Da)). S6 
was phosphorylated in progesterone-stimulated oocytes, but only weakly phosphorylated 
in the constitutively active MAP kinase kinase-microinjected oocytes, and not 
phosphorylated at all in the untreated oocytes. This indicates that the constitutively active 
MAP kinase kinase that was used was only partially active. Therefore, the lack of effect 
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Figure 16. MAP kinase kinase does not appear to activate the Na+/H+ antiporter. 
Oocytes were incubated in 14C-DMO and were left untreated (Cont.), treated with 
progesterone (1 µM), or microinjected with MAP kinase kinase (6.0 ng/oocyte). The pHi 
of the oocytes microinjected with MAP kinase kinase was statistically different from the 
pHi of the progesterone-treated oocytes, but statistically similar to the pHi of the oocytes 
that were left untreated. Columns with different letters above them are significantly 
different from each other using Tukey's multiple comparison test. The data are presented 






Figure 17. Electrophoretic analysis of S6 protein phosphorylation. Oocytes were left 
untreated (lane 1), treated with progesterone (1 µM) (lane 2), or microinjected with MAP 
kinase kinase (6.0 ng/oocyte) (lane 3) and labelled in OR-2 medium with 32p_ 
orthophosphate (100 µCi/ml) for 8 hours. Protein was extracted from each of the 
treatment groups and run on a 10% SDS-polyacrylamide gel. Phosphorylation of the S6 
protein (32,000 kDA) was observed in both the progesterone-treated oocytes and in the 
MAP kinase kinase-microinjected oocytes, but not in the untreated oocytes as compared 
with 14C-methylated protein markers (lane not shown). 
CHAPTER IV 
DISCUSSION 
One of the physiological events occurring during oocyte meiotic maturation is an 
increase in oocyte pHi. Previous studies have shown that this increase in pHi appears to 
be the result of the activation of N a+/H+ antiporters present in the plasma membrane of the 
oocyte. If the extracellular sodium is replaced with choline chloride, or if amiloride (a 
Na+/H+ antiporter inhibitor) is used, the increase in pHi in response to progesterone 
stimulation is completely inhibited (Wasserman and Houle, 1984; Stith and Maller, 1985; 
Towle et al., 1991; Rezai, 1994). The increase in pHi during Xenopus laevis oocyte 
meiotic maturation has been shown to be very important for preparing the egg for 
fertilization with the sperm (Houle and Wasserman, 1983). To understand better the role 
of pH during these cellular processes, an understanding of how the Na+/H+ antiporter is 
regulated during oocyte meiotic maturation needs to be obtained. The Na+/H+ antiporter 
in other cell systems is proposed to be regulated by a phosphorylation event. It has been 
hypothesized that addition of phosphates induces a conformational change in the structure 
of the Na+/H+ antiporter, the result of which is an increased affinity for cytoplasmic 
hydrogen ions (Wakabayashi et al., 1992; Borgese et al., 1992). In support of this 
hypothesis, investigators have demonstrated that as anti.porter activity increases, there is a 
concurrent increase in the phosphorylation of NHEl (Na+/H+ exchanger 1), a 
transmembrane glycoprotein of 110 kDa, in fibroblasts, epithelial cells, and blood platelets 
(Livne et al .. , 1991; Sardet et al., 1990; Wakabayashi et al., 1992; Grinstein et al., 1992; 
Guizouarn et al., 1993). 
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In Xenopus oocytes, studies have been pe:rf ormed to investigate the possible role 
of certain protein kinases in regulating the Na+JH+ antiporter. Through use of various 
inhibitors and activators, it was determined that Protein Kinase C, Protein Kinase A, and 
Calcium-Calmodulin Kinase were not involved in regulation of the Na+/H+ antiporter 
(Rezai, 1994). In addition, MPF H-1 kinase was also found not to play a role in 
regulating this antiporter (Rezai, 1994). Oocytes stimulated with progesterone undergo 
meiotic maturation and a series of protein kinases are phosphorylated, and subsequently 
activated, forming a protein kinase cascade. This cascade consists of the following 
protein kinases: c-mos kinase, raf-1 kinase, MAP kinase kinase, MAP kinase, and S6 
kinase. Preliminary investigations of the possible role of c-mos kinase (the first kinase 
within the cascade) in activation of the Na+ JH+ antiporter in Xenopus oocytes have been 
performed in our laboratory. The results of these studies indicated that high doses of 
microinjected c-mos protein can cause an increase in oocyte pHi (Rezai, 1994). It could 
not be concluded however, whether c-mos kinase itself or a protein kinase downstream of 
c-mos was responsible for the activation of the Na+JH+ antiporter. 
In the current study, c-mos kinase, as well as the other protein kinases within the 
cascade, were examined for their potential role in regulating the Na+/H+ antiporter during 
progesterone-induced oocyte meiotic maturation. The first protein kinase that was 
investigated was c-mos kinase. The proto-oncogene product p39 c-mos kinase has been 
proposed to be the "initiator" of oocyte maturation. Active c-mos kinase has been shown 
to induce GVBD when microinjected into stage VI oocytes in the absence of progesterone 
stimulation (Sagata et al., 1989). It was further demonstrated that oocytes pre-treated with 
cyclohexirnide (an inhibitor of protein synthesis) and then microinjected with active c-mos 
protein underwent GVBD in the absence of progesterone, while oocytes pre-treated with 
cycloheximide and then stimulated with progesterone did not undergo GVBD (Yew et al., 
1992). From these experiments it appears that c-mos kinase is the only newly synthesized 
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protein needed in the oocyte to trigger GVBD. Preliminary experiments indicated that 
high doses of c-mos kinase appeared to play a role in regulating the Na+fH+ antiporter in 
Xenopus oocytes (Rezai, 1994). Based on the results from the current study, it appears 
that lower doses of c-mos kinase (down to 5 ng of total protein per oocyte) are also 
capable of causing an increase in oocyte pHi similar to the increase induced by 
progesterone (Figure 3). These results support the earlier conclusion that c-mos kinase 
does play a role in activation of the Na+/H+ antiporter inXenopus oocytes. 
We do not know what the endogenous level of active c-mos kinase is in 
progesterone-stimulated oocytes. The results from experiments performed by other 
investigators have shown that low doses of injected c-mos kinase have an effect on GVBD 
as well as MAP kinase activity. 2-5 ng c-mos protein injected per oocyte were capable of 
inducing an increase in MAP kinase activity and GVBD (Matten et al., 1994). In the 
current study, I was unable to determine the exact amount of~ c-mos protein being 
injected into each oocyte. Several factors must be taken into consideration when 
calculating the amount of c-mos kinase that was injected, such as the actual amount of 
active c-mos kinase versus the total amount of c-mos protein present in the preparation. 
There is also the problem of leakage of c-mos kinase from the injection wound. 
Precautions such as injecting deeper into the oocyte cytoplasm and not withdrawing the 
pipette immediately after delivery were taken to minimize this from occurring. Even with 
all of these assumptions, I was probably injecting excess active c-mos kinase into the 
oocytes. 
We know that c-mos kinase appears to be the only newly synthesized protein 
needed to trigger GVBD (Yew et al., 1993). A previous study from our laboratory 
showed that oocyte protein synthesis is also necessary for the increase in oocyte pHi in 
response to progesterone (Rezai, 1994). The results from the current study injecting c-
mos kinase into cycloheximide-treated oocytes indicate that c-mos kinase appears to be the 
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only newly synthesized protein needed to activate the Na+JH+ antiporter (Figure 4). 
These results indicated that c-mos kinase plays a role in the activation of the Na+JH+ 
antiporter. In order to determine if c-mos kinase is activating the antiporter directly or 
through the activation of a pre-existing protein kinase located downstream in the cascade 
needed to be examined. 
During progesterone-induced oocyte meiotic maturation, adenylate cyclase activity 
is inhibited, resulting in a decrease in intracellular cAMP and PKA activity (Sadler and 
Maller, 1981). It has been shown that if intracellular cAMP is artificially maintained at 
elevated levels, steroid-treated oocytes will neither undergo GVBD (Maller and Krebs, 
1977; Schorderet-Slatkine et al., 1982; Matten et al., 1994) nor exhibit an increase in pHi 
(Rezai, 1994). Artificially elevated levels of intracellular cAMP did not appear to be 
antagonistic toward c-mos kinase's ability to activate the Na+{H+ antiporter. Oocytes pre-
treated with either forskolin (an activator of adenylate cyclase) or 8-Br-cAMP (a cAMP 
derivative capable of passing through the oocyte's plasma membrane) and then 
microinjected with c-mos kinase exhibited a normal increase in pHi. These results indicate 
that the cAMP/PKA block to activating the antiporter is located in the progesterone-
pathway upstream of c-mos kinase. 
The effect of cAMP/PKA on c-mos kinase has been studied in Dr. Vande Woude's 
laboratory. They showed that microinjection of the catalytic subunit of PKA inhibited 
progesterone-induced translation of c-mos mRNA as well as the activation of downstream 
MAP kinase. If, however, the catalytic subunit of PKA was coinjected with active c-mos 
protein, MAP kinase was activated (Matten et al., 1994). These results suggest that the 
catalytic subunit of PKA acts as a negative regulator during meiotic maturation, blocking 
translation of c-mos kinase mRNA, and thus blocking the kinase cascade. Microinjection 
of the catalytic subunit of PKA was not performed in the current study, but intracellular 
levels of cAMP were artificially elevated. Elevated levels of cAMP should have then 
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bound the regulatory subunits of endogenous PKA, freeing the catalytic subunits, yielding 
a result similar to injecting the catalytic subunits themselves. By injecting active c-mos 
protein, the mRNA translation block by PKA was bypassed. Therefore, the activation of 
the Na+JH+ antiporter indicated that the activator is either c-mos kinase or a protein kinase 
activated downstream of c-mos. 
Ribosomal protein S6 kinase, when activated, is responsible for phosphorylating 
the 40S ribosomal protein S6 during oocyte meiotic maturation. S6 kinase is also one of 
the most downstream protein kinases within the cascade (Wasserman and Houle, 1984). 
Active S6 kinase, however, does not cause activation of the Na+/H+ antiporter when 
microinjected into oocytes. A high dose (50 ng of protein per oocyte) of S6 kinase failed 
to increase oocyte pHi when microinjected into stage VI oocytes. The activity of the 
injected S6 kinase was confirmed by monitoring phosphorylation of ribosome S6 in the 
injected oocytes. It can therefore be concluded that S6 protein kinase is not responsible 
for the activation of the Na+fH+ antiporter. 
Based on the results thus far, the protein kinase that activates the Na+/H+ 
antiporter may be c-mos kinase, or a kinase downstream of c-mos kinase and upstream of 
S6 kinase within the protein kinase cascade. The kinase which immediately follows c-
mos within the cascade has not yet been determined. It has been shown through use of 
oncogenic as well as dominant negative mutant rnRNAs that raf-1 kinase is necessary for 
progesterone-induced oocyte meiotic maturation and that it functions downstream of c-
mos (Muslin et al., 1993). I was unable to obtain raf-1 kinase protein as with c-mos 
kinase and S6 kinase. I was, however, able to obtain transcription vectors coding for 
three forms of raf-1 kinase: wild-type (wt), constitutively active (~N'), and kinase-
deficient (KD). The three vectors were linearized and then transcribed in vitro. All three 
raf-1 mRNAs were efficiently translated into protein when injected into oocytes (Figure 
11). mRNAs for wt-raf-1 and KD-raf-1 did not induce an increase in pHi or GVBD when 
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injected into oocytes, but, AN'-raf-1 mRNA did induce both an increase in pHi and 
GVBD in injected oocytes (Figures 12 and 13). Based on these preliminary results, it 
would appear that a high dose of AN'-raf-1 mRNA (10 ng per oocyte) was capable of 
activating the Na+JH+ antiporter in Xenopus oocytes. Lower doses of AN'-raf-1 mRNA 
were also capable of inducing an increase in oocyte pHi. As shown in Figure 13, 
concentrations as low as 1.25 ng AN'-raf-1 mRNA per oocyte were able to induce a 
significant increase in oocyte pHj, with 2.5 ng mRNA per oocyte and higher inducing an 
increase in pHi similar to that caused by progesterone. These concentrations of mRNA 
were based on absorbance readings taken of each stock sample. Individual dilutions were 
made as needed to obtain the proper concentration of mRNA for injection. The actual 
concentration of newly synthesized~ raf-1 protein could not be determined due to 
problems such as leakage of the mRNA out of the injection site, the amount of protein 
made in the oocyte, and the activity of the translated protein. Active raf-1 kinase, 
however, does appear to play a role in the activation of the Na+JH+ antiporter during 
oocyte meiotic maturation. I cannot conclude, however, if raf-1 kinase acts directly on the 
Na+/H+ antiporter, or if it is a protein kinase located downstream of raf-1 within the 
protein kinase cascade. 
Results from experiments carried out in other cell systems propose the following 
model for raf-1 kinase activation. Activated ras protein recruits inactive raf-1 kinase to the 
plasma membrane of the cell by binding to the amino-terminal region of the raf-1 protein. 
Once at the membrane, the complex is anchored by cytoskeletal elements and an unknown 
factor unfolds the amino-terminal domain of raf-1 off of the catalytic domain, exposing the 
activation sites, serine residues 259 and 621, for phosphorylation. Once raf-1 kinase is 
phosphorylated and activated it is released from ras (Stokoe et al., 1994; Daum et al., 
1994; Williams et al., 1994 ). Based on this proposed model, active raf-1 kinase is located 
near the plasma membrane of the cell. This places raf-1 kinase in close proximity to the 
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Na+/H+ antiporters allowing raf-1 kinase the opportunity to phosphorylate the Na+/H+ 
antiporters directly. 
Progesterone normally causes a decrease in intracellular levels of cAMP, which, if 
artificially maintained elevated, inhibit progesterone's ability to activate the antiporter. 
Elevated levels of intracellular cAMP did not appear to be antagonistic toward c-mos 
kinase's ability to cause an increase in oocyte pHi. To determine if elevated levels of 
intracellular cAMP had any influence on .6N'-raf-1 kinase's ability, similar experiments 
were performed. Oocytes pre-treated with forskolin or 8-Br-cAMP and then injected with 
t\N'-raf-1 mRNA exhibited a full increase in oocyte pHi (Figures 14 and 15). These 
results, along with the results for c-mos kinase, indicate that the cAMP/PKA block is 
upstream of both raf-1 kinase and c-mos kinase within the progesterone-stimulated 
pathway. 
The only known physiological substrate forraf-1 kinase within the protein kinase 
cascade is thought to be MAP (Mitogen Activated Protein) kinase kinase. Recently, a 
group of researchers have shown that cdc25 phosphatase associates with raf-1 kinase in 
mammalian somatic cells and in frog meiotic oocytes (Galaktionov et al., 1995). The 
interaction between cdc25 and raf-1 kinase occurred at the carboxy-terminal region of raf-
1 kinase, which the investigators believe suggests a strong and specific interaction 
between the two proteins. Further studies need to be carried out to determine if raf-1 
kinase could possibly have multiple substrates. 
MAP kinase kinase has been shown to be phosphorylated both in vitro as well as 
in vivo by raf-1 kinase (Dent et al., 1992; Huang et al., 1993). Active MAP kinase kinase 
in turn activates MAP kinase within the protein kinase cascade. The c-mos kinase and raf-
1 kinase experiments suggest that the protein kinase responsible for regulating the Na+/H+ 
antiporter is either raf-1 kinase or a kinase downstream of raf-1 kinase. The S6 kinase 
experiments suggest that the Na+fH+ antiporter activating protein kinase is upstream of it, 
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therefore, MAP kinase kinase was the next protein kinase to be investigated. 
Oocytes which were microinjected with constitutively active MAP kinase kinase 
did not exhibit an increase in pHj. As seen in Figure 16, the pHi level of oocytes injected 
with constitutively active MAP kinase kinase remained at basal pHi levels (control level) 
when compared to the pHi level in progesterone-stimulated oocytes. To accept these 
negative results, the activity of the microinjected MAP kinase kinase needed to be 
determined. The activity of injected MAP kinase kinase protein can be monitored by 
observing phosphorylation of a substrate known to be located downstream of MAP kinase 
kinase. Ribosomal S6 protein was monitored for phosphorylation in oocytes 
microinjected with MAP kinase kinase. This level was compared to ribosomal S6 protein 
phosphorylation in oocytes stimulated with progesterone. The results indicated that the 
constitutively active MAP kinase kinase was only partially active. This may explain why 
there was no increase in oocyte pHi in oocytes injected with this protein. Further studies 
need to be performed with very active MAP kinase kinase before any conclusion can be 
made. Since S6 kinase had no effect on pHj, and MAP kinase kinase had no effect on 
pHj, the intermediate kinase, MAP kinase, was not investigated. 
Based on the results obtained in this and other studies, the following model of 
the role of protein kinases in regulation of the Na+JH+ antiporter is proposed (Figure 18). 
Cycloheximide inhibits progesterone's ability to activate the Na+/fl+ antiporter but not that 
of injected c-mos protein, indicating that the block is located between the progesterone 
receptor and c-mos kinase within the cascade. Cycloheximide is most likely blocking 
translation of endogenous c-mos mRNA. Elevated levels of cAMP/PKA inhibit 
progesterone's ability to activate the Na+/fl+ antiporter but not c-mos kinase's or raf-1 
kinase's ability to do so. This places the cAMPJPKA block between the progesterone 
receptor and c-mos kinase. Data from Dr. Vande Woude's laboratory indicates that 
elevated levels of cAMP/PKA block the cytoplasmic polyadenylation and translation of c-
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mos mRNA. Both c-mos kinase and raf-1 kinase can activate the Na+fH+ antiporter while 
S6 kinase does not. A previous study has also ruled out MPF (Hl kinase) (Rezai, 1994). 
The results from this study indicate that MAP kinase kinase does not activate the Na+/H+ 
antiporter, but the activity of the protein preparation used is questionable, so further 
experimentation with a more active protein preparation are needed to confirm these 
findings. Based on the results of this study and the model of raf-1 kinase activation by 
translocation to the membrane, it can tentatively be concluded that raf-1 kinase may 
directly phosphorylate and activate the Na+JH+ antiporter in Xenopus oocytes during 
meiotic maturation. 
I PROGESTERONE I 
r-- cycloheximide 
r-- cAMP/PKA 
c-mos Kinase mRNA 
{polyadenylation and translation) 
I 
' raf-1 Kinase -- Na+/H+ Antiporter (Activation) 
I 











Figure 18. A proposed model for the role of protein kinases in the regulation of the 
Na+/H+ antiporter in Xenopus laevis oocytes during progesterone-induced meiotic 
maturation. Solid arrows indicate direct protein-protein interaction, while dashed arrows 
indicate indirect action. 
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